slides · global inventory
Source Note
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,355
Current window 75,751-75,780
Pages 3,679
Rows per page 30
Component
75,751-75,780 of 110,355
38
The slide uses a two-column layout (Preclinical vs Clinical) to position the company's lead asset against competitors.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Market Sizing1 hit
40
The slide uses western blot imagery to show protein expression levels (P-RSK, P-ERK, GAPDH) over time (0-72h) to prove the efficacy of ERAS-007.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations 1 hit
02
Essity | Results Presentation Deck | 30 slidesEssity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · Setup1 hit
09
Uses a waterfall chart to explain sales growth and circular callouts for key performance indicators.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
10
The slide uses bar charts to visualize financial performance trends.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
12
The slide uses a callout circle to emphasize the current proposed dividend and an arrow overlay to visualize the growth trend.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
13
The slide uses a grid of circular callouts to present financial KPIs.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
14
The chart uses a standard waterfall bridge format to explain sales growth components.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
15
The chart uses a waterfall-bridge structure to explain margin variance.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · DevelopmentLoop · Pareto Focus1 hit
17
The waterfall chart uses a break in the axis to represent the growth components between the two net sales bars.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · DevelopmentLoop · Pareto Focus1 hit
19
Uses a waterfall-bridge chart to explain the change in Net Sales.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · DevelopmentLoop · Pareto Focus1 hit
21
The slide uses a waterfall-style bridge to explain sales growth, followed by two circular callouts for profitability metrics.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · DevelopmentLoop · Pareto Focus1 hit
25
The slide uses a brand-specific image of a baby to reinforce the 'Libero' brand context.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · Reflection1 hit
26
Essity | Results Presentation Deck | 30 slidesEssity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · Reflection1 hit
04
Exscientia | Investor Day Presentation Deck | 90 slidesExscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · InterestLoop · Logic Chain1 hit
10
The slide uses a horizontal bar chart structure to represent clinical development stages.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · InterestLoop · Logic Chain1 hit
11
Exscientia | Investor Day Presentation Deck | 90 slidesExscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Desire1 hit
22
The scatter plot highlights a specific cluster of compounds (labeled 1 and 2) that were selected by the active learning model despite being outside the typical high-potency/high-score Pareto frontier.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
23
The slide highlights technical infrastructure and R&D capabilities.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
26
The slide features a 3D molecular model and a set of circular gauges representing various drug discovery metrics (potency, stability, toxicity, etc.).Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
31
DMT cycle = design-make-test cycleExscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
37
The slide uses a circular process flow to represent the R&D pipeline.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
38
The slide uses a process flow diagram to illustrate a specific patient journey.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
39
Kaplan-Meier survival curves comparing PFS1 (prior treatment) vs PFS2 (study treatment).Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
41
The slide uses a complex visual mapping to show drug response across two different biological models (patient samples vs cell lines).Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
42
The slide uses a small multiples approach to show dose-response curves for individual patient samples, followed by a summary box plot on the right.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
48
The slide uses a biological pathway diagram to explain the mechanism of action and a honeycomb diagram to illustrate market breadth.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
51
The slide presents preclinical efficacy data for a CDK7 inhibitor ('617) in ovarian (OVCAR3) and triple-negative breast cancer (HCC70) models.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
54
The slide uses a Venn diagram to show gene overlap and line charts to show dose-response relationships for POLR2A and HNRNPDL.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
60
The slide highlights the potential for '539 to address brain metastases in SCLC patients.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit